Progress in HER2-Positive Gastroesophageal Adenocarcinoma

123102



123102 (MedPage Today) — After a period of relative inactivity, therapeutic development in HER2-positive gastroesophageal adenocarcinoma (GEA) has evolved rapidly over the past 5 years, establishing a new standard of care that was supplanted by another…



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *